Welcome to our dedicated page for Emagin news (Ticker: EMAN), a resource for investors and traders seeking the latest updates and insights on Emagin stock.
eMagin Corporation (EMAN) is a pioneer in the field of organic light-emitting diode (OLED) microdisplays and virtual imaging technologies. The company specializes in designing, developing, manufacturing, and marketing OLED-on-silicon microdisplays, which are utilized in various sectors including defense, commercial, medical, and industrial markets.
eMagin's cutting-edge virtual imaging products leverage their proprietary OLED technology to create high-resolution microdisplays. These displays, which are typically smaller than one inch, are integrated into silicon backplanes or chips. When viewed through a magnifier, these microdisplays produce virtual images that appear as large as a computer monitor or high-definition television.
The company’s products are crucial for Original Equipment Manufacturers (OEMs), enabling the development and marketing of improved or entirely new products. Their diverse applications extend from military head-mounted displays to advanced medical imaging equipment.
Recently, eMagin made headlines with its strategic progress. A notable development is the planned merger with Samsung Display Co., which will be decided in a Special Meeting of Stockholders scheduled for August 31, 2023. This merger represents a significant step toward expanding eMagin’s influence and capabilities within the OLED microdisplay market.
Financially, eMagin is maintaining a stable trajectory, continuing to innovate and partner with leading entities across its operational sectors. With a strong commitment to advancing virtual imaging technologies, eMagin is well-positioned to remain at the forefront of the industry.
eMagin Corporation (NYSE American: EMAN) expects total revenues for Q4 2022 to range between $8.1 million and $8.3 million, marking an increase from $7.2 million in Q4 2021. Product revenues are estimated at $7.6 million to $7.8 million, reflecting a 9% to 11% rise year-over-year. The company anticipates a year-end backlog of $16.7 million, with strong bookings exceeding $7.8 million in Q4. eMagin also ordered advanced manufacturing equipment under its $34 million Defense Production Act funding, expected to enhance production.
eMagin Corporation (NYSE American: EMAN) has received an order worth approximately $1.7 million for high-brightness OLED microdisplays from Collins Aerospace, intended for use in the F-35 Helmet Mounted Display System (HMDS). This order underscores eMagin's reputation for providing crucial technology in military applications. The F-35 Lightning serves as a sophisticated jet fighter, and the HMDS is essential for operational effectiveness. eMagin continues to lead in OLED microdisplay technology, serving various markets including military and consumer sectors.
eMagin Corporation (NYSE American: EMAN) announced its participation in the FLORetina ICOOR 2022, taking place from December 8-11 in Rome, Italy. The company will showcase its high-resolution OLED microdisplays tailored for medical applications, particularly in ophthalmology. These displays promise high contrast, a wide color gamut, and ultra-high resolution, making them ideal for imaging, diagnosis, and surgical education. eMagin is recognized as the only US manufacturer of OLED displays and aims to revolutionize visual technology for various sectors.
eMagin Corporation (NYSE American: EMAN) reported third-quarter 2022 total revenues of $7.6 million, marking a 31% year-over-year increase. Positive EBITDA of $0.7 million was achieved, with gross margin improving to 37% from 10% last year. The company’s backlog of open orders rose to $16.6 million, driven by strong military and medical demand. A $2.5 million contract with the U.S. Army was recognized, contributing to revenue growth. Operating loss decreased to $0.1 million, while net loss was $0.3 million. Improved production capabilities from government-funded equipment are expected to enhance future performance.
eMagin Corporation (NYSE American: EMAN) anticipates third-quarter revenues between $7.4 million and $7.6 million, marking a significant increase of 28% to 31% from $5.8 million in Q3 2021. This revenue growth is attributed to heightened military demand, increased contributions from medical sectors, and better contract revenue tied to development activities. The company's backlog is expected to be $16.6 million, up from $14.9 million in the previous year. eMagin will release full results on November 10, 2022.
eMagin Corporation (NYSE American: EMAN) announced that its COO, Dr. Amal Ghosh, will present an invited paper titled "OLED-on-Silicon Microdisplays" at the OLEDs World Summit in San Francisco on October 27, 2022. The presentation will highlight the advancements in OLED-on-Silicon technology, emphasizing its significance in AR/VR applications due to recent brightness improvements. This session will cover essential display requirements for AR/VR and how eMagin's innovations position them favorably in the market.
eMagin Corporation (NYSE American: EMAN) reported a 14% increase in Q2 2022 revenue to $7.2 million, with a gross margin improvement to 22% from 9% year-over-year. The total backlog of open orders stood at $14.3 million, driven by strong military and medical demand. Notable achievements included a $2.5 million contract from the U.S. Army for high-performance microdisplays and a People’s Choice Award at Display Week 2022. Operating loss narrowed to $1.8 million, while net loss was $1.4 million. Cash reserves totaled $4.3 million, with ongoing upgrades expected to enhance future performance.
eMagin Corporation (NYSE American: EMAN) will release its second-quarter results on August 11, 2022. The management team will host a conference call and webcast at 9:00 a.m. ET to discuss the quarterly results and outlook. eMagin is a leader in high-resolution micro OLED displays catering to various sectors including military and consumer markets. The company’s unique Direct Patterning Technology (dPd™) is set to revolutionize information consumption. Details for participating in the call are available on the company’s investor relations website.
eMagin Corporation (NYSE American: EMAN) announced that Chief Operating Officer Dr. Amal Ghosh will present at the 22nd International Meeting on Information Display (IMID 2022) in Busan, South Korea, from August 23-26. Dr. Ghosh's presentation, titled OLED Microdisplays for AR/VR Applications, is scheduled for August 26, while he will also conduct a tutorial on AR/VR on August 23. eMagin specializes in high-resolution micro OLED displays, crucial for various applications including military and consumer markets.
FAQ
What is the market cap of Emagin (EMAN)?
What does eMagin Corporation specialize in?
What are OLED microdisplays?
What are the applications of eMagin’s products?
Who are eMagin’s primary customers?
What recent achievement has eMagin Corporation announced?
How does eMagin's OLED technology work?
What is the significance of the merger with Samsung Display Co.?
In which markets does eMagin operate?
What are virtual images in the context of eMagin’s products?
How is eMagin performing financially?
